NL-OMON46563已完成不适用
A phase I, open label study to investigate the absorption, metabolism and excretion of 14C-ESN-364 in healthy menopausal female volunteers. - 14C-ESN-364 ADME Study
Ogeda0 个研究点目标入组 6 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy female menopausal subjects
- •40-75 years, inclusive,
- •BMI 18.0-30.0 kg/m2, inclusive
- •50.0-100.0 kg, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
A phase I, open-label study to investigate the absorption, metabolism, excretion, and mass balance of [14C]QLT091001 following single oral dose in healthy male subjectsNL-OMON35776QLT Inc.6
已完成
不适用
A phase 1, open-label study to investigate the absorption, metabolism, excretion, and mass balance of [14C]pacritinib following a single oral dose in healthy male subjects.Chronic Myeloproliferative Disordersabnormal growth of blood cells in the bone marrowMyeloproliferative disordersNL-OMON41159CTI BioPharma Corporation6
已完成
1 期
A mass-balance study of [14C]KDT-3594 in healthy adult maleHealthy conditionJPRN-jRCT2071220057Shimizu Yoshitaka8
已完成
不适用
A phase 1, open-label study to characterize the absorption, metabolism and excretion of 14C-JNJ-63623872 after a single dose in healthy male subjectsInfluenza ARNA-virus10047438NL-OMON42724Janssen-Cilag6
已完成
不适用
A phase 1, open-label study to characterize the absorption, metabolism, and excretion of 14C-JNJ-53718678 after a single oral dose in healthy adult male subjectsRSV10047438NL-OMON43122Janssen Sciences Ireland UC6